Recombinant Anabaena variabilis Lipoprotein signal peptidase (lspA)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Anabaena variabilis Lipoprotein Signal Peptidase (LspA)

Lipoprotein signal peptidase (LspA) is an essential enzyme in bacterial cell envelope biogenesis, responsible for cleaving signal peptides from prolipoproteins. In Anabaena variabilis, a filamentous cyanobacterium, LspA is encoded by the lspA gene (locus tag: Ava_2475) and plays a critical role in processing lipoproteins required for cellular functions such as nutrient uptake and stress response . The recombinant form of this enzyme, produced via heterologous expression in Escherichia coli, retains its catalytic activity and structural integrity, making it a valuable tool for biochemical and pharmaceutical research .

Expression and Purification

The recombinant protein is expressed in E. coli with an N-terminal His tag for affinity purification. Key parameters include:

  • Expression vector: pET28a .

  • Storage: Tris-based buffer with 50% glycerol at -20°C .

  • Purity: Confirmed via SDS-PAGE and activity assays .

Comparative Analysis with Orthologs

Recombinant A. variabilis LspA shares functional similarities with LspA enzymes from other bacteria but exhibits unique structural adaptations:

FeatureA. variabilis LspAStaphylococcus aureus LspAPseudomonas aeruginosa LspA
EssentialityNon-essential in vitro Non-essential Essential
Substrate specificityGram-negative lipoboxesGram-positive lipoboxesBroad specificity
Inhibitor sensitivityResistant to globomycin Sensitive to globomycin Sensitive to myxovirescin

This divergence highlights evolutionary adaptations to ecological niches and antibiotic pressures .

Enzyme Assays and Drug Discovery

Recombinant LspA is used to screen inhibitors targeting lipoprotein processing, a validated antibacterial strategy. For example:

  • Globomycin: Inhibits LspA in P. aeruginosa but not in A. variabilis, guiding species-specific drug design .

  • Myxovirescin: Binds a distinct region of the substrate-binding pocket, revealing new druggable sites .

Diagnostic Tool Development

The protein is commercially available as an ELISA reagent (Cat. No. CSB-CF662099BYN) for immunological studies, enabling:

  • Quantification of LspA expression in cyanobacterial cultures .

  • Antibody validation for lipoprotein-processing research .

Genomic Localization

The lspA gene (Ava_2475) resides in a genomic region associated with cell envelope biosynthesis in A. variabilis ATCC 29413. Adjacent genes encode transporters and lipid-modifying enzymes, suggesting coordinated regulation .

Bioproduction Challenges

Despite successful expression in E. coli, optimizing soluble yields requires:

  • Low-temperature induction: 25°C to prevent aggregation .

  • Culture media optimization: Terrific Broth (TB) enhances protein solubility .

Future Directions

  • Structural studies: High-resolution crystallography to map inhibitor-binding sites .

  • Directed evolution: Engineering thermostable variants for industrial applications .

  • Ecological impact: Investigating LspA’s role in akinete dormancy and heterocyst differentiation .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate specific format requirements. Please indicate your desired format when placing your order, and we will do our best to fulfill your request.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please contact your local distributor for specific delivery time information.
Note: Our standard shipping includes blue ice packs. If dry ice is required, please inform us in advance and additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%, which can be used as a reference.
Shelf Life
The shelf life is influenced by various factors including storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, liquid form has a shelf life of 6 months at -20°C/-80°C. Lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
lspA; Ava_2475; Lipoprotein signal peptidase; Prolipoprotein signal peptidase; Signal peptidase II; SPase II
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-158
Protein Length
full length protein
Species
Anabaena variabilis (strain ATCC 29413 / PCC 7937)
Target Names
lspA
Target Protein Sequence
MRFKNRLFWIAAFIAFFVDQLTKYWVVQTFSLGETLPILPGIFHFTYVTNTGAAFSLFSG KVEWLRWLSLGVSLLLIGLALLGPVLERWDQLGYGLILGGAMGNGIDRFALGYVVDFLDF RLINFAVFNMADSFISIGIVCLLLASLQKSPDSHHRSR
Uniprot No.

Target Background

Function
This protein specifically catalyzes the removal of signal peptides from prolipoproteins.
Database Links
Protein Families
Peptidase A8 family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the basic structural composition of Anabaena variabilis lspA?

Lipoprotein signal peptidase (lspA) from Anabaena variabilis (strain ATCC 29413 / PCC 7937) is a 158 amino acid protein with a molecular mass of 17.8 kDa . It belongs to the peptidase A8 family and has a complete amino acid sequence: MRFKNRLFWIAAFIAFFVDQLTKYWVVQTFSLGETLPILPGIFHFTYVTNTGAAFSLFSGKVEWLRWLSLGVSLLLIGLALLGPVLERWDQLGYGLILGGAMGNGIDRFALGYVVDFLDFRLINFAVFNMADSFISIGIVCLLLASLQKSPDSHHRSR . As a type II signal peptidase, lspA contains several transmembrane domains that anchor it to the membrane, with conserved catalytic residues positioned to cleave signal peptides from prolipoproteins.

What are the optimal conditions for expressing recombinant A. variabilis lspA?

For optimal expression of recombinant A. variabilis lspA, researchers should consider the following parameters:

Based on studies of bacterial signal peptidases, inducing expression at OD600 of 0.6-0.8 with 0.5 mM IPTG and subsequent growth at 25°C for 16-18 hours typically yields the best balance between expression level and proper folding.

What strategies help overcome challenges in purifying active recombinant lspA?

Purifying active lspA presents several challenges due to its membrane-associated nature. Successful purification strategies include:

  • Detergent Selection: Initial extraction with stronger detergents (1% DDM or 1% Triton X-100) followed by exchange to milder detergents (0.05% DDM or LMNG) during purification helps maintain stability while preserving activity.

  • Buffer Optimization: Including glycerol (10-20%) and stabilizing agents such as specific lipids (E. coli polar lipid extract at 0.1 mg/mL) improves protein stability during purification.

  • Two-Step Purification Protocol:

    • Initial IMAC (immobilized metal affinity chromatography) using Ni-NTA for His-tagged lspA

    • Followed by size exclusion chromatography to separate aggregates and obtain homogeneous protein

  • Activity Preservation: Addition of reducing agents (1-5 mM DTT or 2-10 mM β-mercaptoethanol) helps maintain the reduced state of any essential cysteine residues.

Based on comparative analysis with other signal peptidases, purification under slightly alkaline conditions (pH 7.5-8.0) typically preserves enzymatic activity better than acidic conditions.

How can researchers assess the catalytic activity of purified recombinant lspA?

The catalytic activity of purified recombinant A. variabilis lspA can be assessed through several complementary approaches:

  • Genetic Complementation Assay: Similar to the approach used with R. typhi lspA, researchers can test if A. variabilis lspA can restore growth of temperature-sensitive E. coli Y815 (lspA mutant) at non-permissive temperatures . This provides functional evidence of enzymatic activity.

  • In vitro Peptidase Assay: Using synthetic fluorogenic peptide substrates that mimic the lipoprotein signal peptide cleavage site. Activity is measured as an increase in fluorescence upon cleavage of the quenched substrate.

  • Mass Spectrometry-Based Assay: Incubating purified lspA with synthetic prolipoprotein substrates and analyzing the reaction products by MALDI-TOF or LC-MS/MS to detect the specific cleavage products.

A typical reaction buffer composition for in vitro assays includes:

  • 50 mM HEPES (pH 7.5)

  • 150 mM NaCl

  • 0.05% DDM

  • 10% glycerol

  • 1 mM DTT

What approaches reveal structure-function relationships in A. variabilis lspA?

To elucidate structure-function relationships in A. variabilis lspA, researchers can employ the following methods:

  • Site-Directed Mutagenesis: Creating targeted mutations of conserved catalytic residues based on alignment with other type II signal peptidases. Key residues likely include conserved aspartate and lysine residues that form the catalytic dyad typical of peptidase A8 family members.

  • Truncation Analysis: Generating N- and C-terminal truncations to identify domains essential for membrane association, substrate binding, and catalysis.

  • Chimeric Proteins: Creating chimeras between A. variabilis lspA and other bacterial lspA proteins (such as E. coli or R. typhi) to identify regions responsible for substrate specificity.

  • Homology Modeling and Molecular Dynamics: Utilizing existing crystal structures of bacterial signal peptidases to generate structural models of A. variabilis lspA and predict substrate binding sites and catalytic mechanisms.

A typical experimental design would include expressing these variants, measuring their activity using the assays described above, and correlating structural changes with functional outcomes.

What is the relationship between lspA expression and other protein secretion machinery in A. variabilis?

In A. variabilis, researchers should investigate:

  • Coordinated Expression Analysis: Using qRT-PCR to simultaneously monitor transcript levels of:

    • lspA (SPase II)

    • lgt (prolipoprotein diacylglyceryl transferase)

    • lepB (SPase I)

    • secA/secY (components of Sec translocation machinery)

  • Protein-Protein Interaction Studies: Using pull-down assays or bacterial two-hybrid systems to identify direct interactions between lspA and other components of the secretion machinery.

How does A. variabilis lspA differ from homologous proteins in other cyanobacteria and bacteria?

A. variabilis lspA belongs to the peptidase A8 family , a conserved group of enzymes found across bacteria. Comparative analysis reveals:

SpecieslspA LengthIdentity to A. variabilis lspANotable Differences
A. variabilis PCC 7937158 aa100%Reference sequence
R. typhi~170 aa~25-30% (estimated)Higher expression correlation with lgt
E. coli164 aa~30-35% (estimated)Well-characterized catalytic residues
Other cyanobacteria155-165 aa60-90% (estimated)Variations in membrane-spanning regions

Key differences typically exist in:

  • The N-terminal region, which influences membrane topology

  • Substrate binding pockets, affecting specificity for different lipoprotein signal sequences

  • Catalytic efficiency under different pH and temperature conditions, reflecting the organism's environmental niche

A. variabilis, being a moderate thermophile growing well at approximately 40°C , likely possesses a more thermostable lspA compared to mesophilic cyanobacteria, with potential amino acid substitutions that enhance protein stability at higher temperatures.

What is the evolutionary significance of lspA conservation across cyanobacterial species?

The conservation of lspA across cyanobacterial species reflects its essential role in lipoprotein processing. Evolutionary analysis suggests:

  • Functional Conservation: The core catalytic residues and active site architecture of lspA are highly conserved across diverse cyanobacteria, indicating strong selective pressure to maintain lipoprotein processing capability.

  • Adaptive Variations: Sequence variations outside the catalytic core likely represent adaptations to different environmental niches occupied by various cyanobacteria.

  • Co-evolution with Substrates: Changes in lspA sequence may co-evolve with changes in the lipoprotein repertoire of different cyanobacterial species, particularly those that have specialized cellular differentiation like heterocysts and akinetes in A. variabilis .

The presence of lspA across diverse cyanobacteria that diverged over 2 billion years ago highlights its ancient origin and fundamental importance in bacterial physiology, particularly for membrane organization and extracellular communication.

How does lspA function contribute to heterocyst and akinete formation in A. variabilis?

While direct studies linking lspA to heterocyst and akinete formation in A. variabilis are not available from the search results, its role can be hypothesized based on general principles of cellular differentiation in cyanobacteria:

  • Envelope Remodeling: Both heterocysts and akinetes in A. variabilis require extensive cell envelope remodeling, including the formation of specialized glycolipid layers . As a processor of lipoproteins, lspA likely plays a role in ensuring proper localization and function of lipoproteins involved in envelope formation.

  • Stress Response: The formation of heterocysts under nitrogen limitation and akinetes under other stress conditions requires coordinated protein expression and membrane restructuring. Properly processed lipoproteins may serve as stress sensors or structural components during differentiation.

  • Potential Parallel with HglB: Similar to how the HglB protein is essential for glycolipid layer formation in both heterocysts and akinetes , lspA may process lipoproteins that function in both cell types. The observation that "HglB possesses two functional domains, an N-terminal acyl carrier protein (ACP) domain and a C-terminal thioester reductase (TER) domain" suggests complex protein machinery is required for envelope formation.

What methodologies can determine if lspA mutants affect specialized cell envelope formation?

To investigate whether lspA affects specialized cell envelope formation in A. variabilis, researchers should employ the following methodologies:

  • Construction of Conditional Mutants:

    • Complete knockout of lspA may be lethal, so conditional expression systems or partial knockdowns should be employed

    • Using inducible promoters to control lspA expression levels during heterocyst or akinete induction

  • Microscopic Analysis:

    • Transmission electron microscopy to examine cell envelope ultrastructure, similar to analyses conducted for hglB mutants

    • Fluorescence microscopy with lipid-specific dyes to analyze membrane composition

  • Biochemical Characterization:

    • Thin-layer chromatography of lipid extracts to detect changes in lipid composition, similar to methods used in Figure 1B of the hglB study

    • Proteomics analysis of cell envelopes to identify mislocalized or unprocessed lipoproteins

  • Functional Assays:

    • Nitrogen fixation assays under aerobic and anaerobic conditions to assess heterocyst function

    • Stress resistance tests (desiccation, freezing, oxidative stress) to evaluate akinete functionality, similar to those conducted for hglB mutants

How can recombinant A. variabilis lspA be utilized as a tool for studying lipoprotein processing?

Recombinant A. variabilis lspA offers several advanced applications for studying lipoprotein processing:

  • In vitro Lipoprotein Processing System: Purified recombinant lspA can be used to establish an in vitro system for studying the specificity and kinetics of lipoprotein signal peptide cleavage. This system would allow:

    • Determination of sequence requirements for efficient processing

    • Screening of potential inhibitors of signal peptidase activity

    • Comparison of processing efficiency across different substrate variants

  • Engineering Signal Peptides for Biotechnology: By understanding A. variabilis lspA specificity, researchers can design optimized signal peptides for:

    • Improved secretion of recombinant proteins in cyanobacterial expression systems

    • Creation of novel surface display systems using cyanobacterial lipoproteins as anchors

  • Structural Biology Platform: As a representative of cyanobacterial signal peptidases, the structure of A. variabilis lspA (determined by X-ray crystallography or cryo-EM) would provide insights into:

    • Adaptations specific to photosynthetic organisms

    • Potential differences in substrate binding compared to other bacterial groups

What experimental approaches can resolve contradictory data about lspA function across different bacterial systems?

When facing contradictory data about lspA function across different bacterial systems, researchers should employ the following approaches:

  • Heterologous Expression and Complementation:

    • Express A. variabilis lspA in E. coli or other bacterial lspA mutants

    • Test functional complementation under various conditions

    • This can determine if functional differences are due to the protein itself or cellular context

  • Domain Swapping Experiments:

    • Create chimeric proteins with domains from different bacterial lspA proteins

    • Test which domains confer specific functional properties

    • This can pinpoint regions responsible for contradictory observations

  • Context-Dependent Activity Analysis:

    • Reconstitute purified lspA in different membrane compositions

    • Test activity with the same substrates under varying conditions (pH, temperature, ionic strength)

    • This can reveal environmental factors that cause apparent contradictions

  • Comprehensive Substrate Profiling:

    • Use proteomics approaches to identify all processed substrates in different systems

    • Compare substrate specificity across different bacterial lspA enzymes

    • This can reveal whether functional differences stem from different substrate repertoires

  • Cross-Validation of Methodologies:

    • Apply multiple independent techniques to measure the same parameters

    • Standardize assay conditions across different research groups

    • This can identify whether contradictions arise from methodological differences rather than true biological variation

What are the most promising areas for future research on A. variabilis lspA?

Based on current knowledge gaps, the most promising research directions include:

  • Structural Characterization: Obtaining high-resolution structures of A. variabilis lspA through X-ray crystallography or cryo-EM would provide unprecedented insights into:

    • Catalytic mechanism

    • Substrate binding specificity

    • Potential for structure-based inhibitor design

  • Systems Biology Integration: Investigating how lspA functions within the broader context of:

    • Cell envelope biogenesis networks

    • Stress response pathways

    • Cellular differentiation programs specific to heterocysts and akinetes

  • Substrate Identification and Validation: Comprehensive identification of all A. variabilis lipoproteins processed by lspA through:

    • Proteomics approaches with emphasis on membrane-associated fractions

    • Bioinformatic prediction followed by experimental validation

    • Correlation of substrate processing with specific cellular functions

  • Regulation Mechanisms: Elucidating how lspA expression and activity are regulated in response to:

    • Environmental stress

    • Developmental cues

    • Interaction with other cellular components

What technological advances would enhance our understanding of lspA structure and function?

Several technological advances would significantly enhance research on lspA:

  • Advanced Membrane Protein Structural Biology:

    • Application of new detergent-free systems like nanodiscs or SMALPs (styrene maleic acid lipid particles) for stable isolation of lspA in a native-like environment

    • Development of improved crystallization methods for membrane proteins

    • Advances in cryo-EM for smaller membrane proteins

  • Single-Molecule Enzymology:

    • Technologies to monitor individual enzyme-substrate interactions in real-time

    • Measurement of conformational changes during the catalytic cycle

    • Correlation of structural dynamics with enzyme function

  • Genetic Engineering in Cyanobacteria:

    • Improved genome editing techniques specific for A. variabilis

    • Development of conditional expression systems with finer temporal control

    • In vivo protein labeling methods for tracking lspA localization during cellular differentiation

  • Computational Approaches:

    • Enhanced molecular dynamics simulations of membrane proteins

    • Machine learning approaches to predict substrate specificity

    • Systems biology models integrating lspA function into cellular networks

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.